Financial Services Commission investigates Shin Poong Pharm on charges of 'unfair trade'

Reporter Paul Lee / approved : 2023-09-22 07:01:01
  • -
  • +
  • 인쇄

 

[Apha Biz=(Chicago) Reporter Paul Lee] The Financial Services Commission has launched a forced investigation into Shinpoong Pharmaceutical to check for unfair stock trading by its executives and employees.

According to the financial investment industry on the 21st, the Financial Services Commission's capital market investigation team conducted an on-site survey of the Shin Poong Pharm headquarters earlier in the day.

Forced investigation is a method of investigation that includes on-site investigation, seizure of data (temporary custody), restoration and analysis of smartphone and hard disk (forensics).

It can quickly respond to stock price manipulation as it can conduct an investigation equivalent to a seizure search without having to go through a court warrant process.

The Financial Services Commission is looking into allegations that executives and employees of Shinpung Pharmaceutical Co. traded stocks using unknown internal information in the market in the process of a surge in Shin Poong Pharm's stock prices in recent years.

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

어플

주요기사

Kim Yoo-seok, Coupang Delivery VP and Chairman’s Brother, Earns $14 Million in Total Compensation2025.12.29
Korea’s Financial Regulator Accused of Interfering in Accounting Standards Chief Appointment2025.12.29
Shinhan Bank Reports KRW 2.96 Billion Financial Incident Linked to Loan Fraud2025.12.29
ABL Bio Receives $40 Million Upfront Payment and $15 Million Equity Investment from Eli Lilly2025.12.29
Shinhan Card Faces Scrutiny After Three-Year Employee Data Leak, Raising Questions About Internal Controls2025.12.29
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사